NITROFINN® – Important additional strenght to Innventa portfolio

By |2018-08-01T18:56:40+00:00August 1st, 2018|News|

NITROFINN® – Important additional strenght to Innventa portfolio

After launching of Serapinn forte®, Forticolinn®, Miocytinn®, Laringinn® and Rhinosinn®, Innventa is continuing with fulfillment of ambitious 2018 new products launch plan. On 20th of July 2018 in Serbian pharmacies  is available new product in Innventa urology portfolio – Nitrofinn®.

Nitrofinn® is currently the only registered Nitrofurantoin on the market, keeping Innventa faitfull to it’s mission: providing inventive pharma solutions to health sector.

Goran Orlic, the general menager of Innventa, stated that introduction of Nitrofinn® represents important milestone in further strong growth in Innventa sales in Serbia and region.